Kristi Dehan-Schmidt

Search results

• 2020

  Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

  Joode, K. D., Groen, H. J. M., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., de Groot, J. W. B., de Wijn, R., Hurkmans, D. P., van den Heuvel, D. M. A., Schmidt, K., Groten, J. P., Verdegaal, E. M. E., van der Burg, S. H., van den Heuvel, M. M., Aerts, J. G. J. V., Kapiteijn, E. & Mathijssen, R. H., Sept-2020, In: Annals of Oncology. 31, p. S788-S788 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic